Stockreport

HQL: Still Offers Attractive Value As Long As Interest Rates Decline [Seeking Alpha]

TeklaLife Sciences Investors  (HQL) 
US:NYSE Investor Relations: teklacap.com/funds/hql
PDF HQL trades at a 7.92% discount to NAV, with its share price historically benefiting from lower interest rates and sector growth initiatives. The fund's focus on incom [Read more]